Pathomics Health’s Post

Unlocking the potential of personalized cancer treatment is crucial in improving patient outcomes. Our approach at Rejuve.Bio mirrors this, harnessing AI to tailor interventions for individual health needs, paving the way for precision medicine advancements. Learn more about Rejuve.Bio and our crowdfund here bit.ly/rjvbcrowdfund https://lnkd.in/ggPQGiis

The Duke University Medical Centre study reveals a higher detection rate of lung cancer, including more advanced stages, compared to the National Lung Screening Trial. This suggests that real-world screening might capture more cases due to differences in population risk profiles or advancements in technology. Despite the high sensitivity and specificity of the Lung-RADS system, the low positive predictive value highlights the challenge of managing false positives. The study underscores the importance of refining LCS protocols to better manage patient follow-up and adapt to diverse clinical environments. This will help maximise early detection benefits while controlling the downsides of screening. #lungscreen #research #clinical

NEW: Advanced Research Projects Agency for Health (ARPA-H) is transforming cancer care with a revolutionary program called ADAPT. How? By exploring cutting-edge technologies to monitor and target the ever-changing tumor landscape. This is how we ADAPT https://lnkd.in/eibMmrkS

An artificial intelligence (AI)-powered breakthrough discovery led by VCHRI researchers could revolutionize the diagnosis and treatment of endometrial cancer worldwide by identifying patients with high-risk disease. “It’s so important that patients with high-risk disease are identified so we can intervene and hopefully prevent recurrence,” says study co-lead Dr. Jessica McAlpine. “This AI-based approach will help ensure no patient misses an opportunity for potentially lifesaving interventions.” Learn more about this research: https://lnkd.in/gQGwF_kB #HealthResearch #ArtificialIntelligence #EndometrialCancer

Have you ever wondered what the growth of a tumor looks like? This latest 3D map gives intricate detail on cells, while helping researchers understand various cancers and what treatment may look like in the future. Learn more from @Nature https://bit.ly/4ebTcs9

🖥️ Really happy that my first article to be published with Klarity is now up! 🚺 Breast cancer is frighteningly common among women globally, but the different types, possible symptoms, risk factors, and treatment options may not always be common knowledge. 🩺 Writing this article really reminded me how important it is that we continue to break down the sometimes overwhelming scientific and medical jargon so that everybody can access information relating to their health. 💪🏼 Knowledge is power, after all. https://lnkd.in/eBbvMrTj

Happy Friday Everyone! 🌟 Exciting News Alert! 🌟 Looking to stay ahead in the world of medical imaging? Check out this groundbreaking study in Nature Portfolio Medicine unveiling a novel risk prediction model that's revolutionizing lung cancer screening uptake! 🚀 🔍 Dive into the details here: https://lnkd.in/g7wseMvH Discover how this innovative approach is enhancing the efficiency and accuracy of CT screenings, potentially saving countless lives. Don't miss out on the future of healthcare—stay informed, stay proactive! 💡 #MedicalInnovation #HealthcareTech #LungCancerScreening

New perspectives on understanding cancer as a systemic disease are reshaping our approach to prevention and treatment. Researchers are diving deep into the complexities of how tumors interact with the body, including the immune system, metabolism, and even circadian rhythms. This comprehensive approach promises better strategies to improve patient outcomes and quality of life. #CancerResearch #MedicalBreakthroughs #HealthInnovation #SystemicDisease #CancerCare #ResearchAdvances #Oncology #Healthcare #PatientCare #ScienceNews

Scientists and healthcare professionals continue to make significant advances in the use of CAR T-cell therapy for the treatment of certain types of cancer. And while these developments are making a major impact on the lives of patients, it is important to address the dangers associated with CAR T-cell therapy. Studies show that 70% of CAR T-cell patients will experience a potentially life-threatening side effect known as Cytokine Release Syndrome (CRS), an overreaction of the immune system. Learn about CytoAgents' progress in developing an effective treatment for CRS: https://cytoagents.com/ #cytokinereleasesyndrome #crs #cytokiens #cartcelltherapy Teresa Whalen, RPh

The "Mediastinal-Lymph-Node-SEG" dataset is now available on TCIA at https://lnkd.in/epMQu6bU! It contains chest CT scans from 513 patients with lymphadenopathy due to illness, such as cancer or infections. Segmentations are also included to help develop new tools from weakly annotated cases. These data were also used for the https://lnkd.in/ey6kr4kY competition at MICCAI.